uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences.ORCID iD: 0000-0001-6120-2683
Show others and affiliations
2008 (English)In: Journal of Molecular Biology, ISSN 0022-2836, Vol. 376, no 5, 1388-1402 p.Article in journal (Refereed) Published
Abstract [en]

The epidermal growth factor receptor 1 (EGFR) is overexpressed in various malignancies and is associated with a poor patient prognosis. A small, receptor-specific, high-affinity imaging agent would be a useful tool in diagnosing malignant tumors and in deciding upon treatment and assessing the response to treatment. We describe here the affinity maturation procedure for the generation of Affibody molecules binding with high affinity and specificity to EGFR. A library for affinity maturation was constructed by rerandomization of selected positions after the alignment of first-generation binding variants. New binders were selected with phage display technology, using a single oligonucleotide in a single-library effort, and the best second-generation binders had an approximately 30-fold improvement in affinity (K(d)=5-10 nM) for the soluble extracellular domain of EGFR in biospecific interaction analysis using Biacore. The dissociation equilibrium constant, K(d), was also determined for the Affibody with highest affinity using EGFR-expressing A431 cells in flow cytometric analysis (K(d)=2.8 nM). A retained high specificity for EGFR was verified by a dot blot assay showing staining only of EGFR proteins among a panel of serum proteins and other EGFR family member proteins (HER2, HER3, and HER4). The EGFR-binding Affibody molecules were radiolabeled with indium-111, showing specific binding to EGFR-expressing A431 cells and successful targeting of the A431 tumor xenografts with 4-6% injected activity per gram accumulated in the tumor 4 h postinjection.

Place, publisher, year, edition, pages
2008. Vol. 376, no 5, 1388-1402 p.
Keyword [en]
Affibody, EGFR, tumor targeting, phage display selection, affinity maturation
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-17042DOI: 10.1016/j.jmb.2007.12.060ISI: 000254585900014PubMedID: 18207161OAI: oai:DiVA.org:uu-17042DiVA: diva2:44813
Available from: 2008-06-16 Created: 2008-06-16 Last updated: 2015-03-24Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Orlova, AnnaTolmachev, Vladimir
By organisation
Biomedical Radiation SciencesDepartment of Medical Sciences
In the same journal
Journal of Molecular Biology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 264 hits
ReferencesLink to record
Permanent link

Direct link